• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN? CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN? CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G150
Medical Device Problem Code High impedance (1291)
Health Effect - Clinical Code Calcium Deposits/Calcification (1758)
Date of Event 06/12/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) system demonstrated a notable decrease in impedance compared to the last in clinic evaluation.A breakdown of the defibrillation vectors indicated directional changes consistent with evolving lead characteristics.Technical services reviewed historical system data and identified a gradual upward trend in baseline in shock lead impedance over several years.Based on the vector patterns and impedance trends, the findings suggest significant calcification of the proximal coil relative to the distal coil.A defibrillation threshold test (dft) should be considered to ensure the system remains effective in a single coil configuration.The healthcare provider acknowledged and understood the recommendation.This device remains in service.This device was not returned for analysis.The product investigation determined that the "known inherent risk of device" investigation conclusion code was selected based on product record and reported observation review.Additional information was received that this crt-d was explanted and returned for analysis.Other than the surgical procedure, no additional adverse patient effects were reported.
 
Event or Problem Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) system demonstrated a notable decrease in impedance compared to the last in clinic evaluation.A breakdown of the defibrillation vectors indicated directional changes consistent with evolving lead characteristics.Technical services reviewed historical system data and identified a gradual upward trend in baseline in shock lead impedance over several years.Based on the vector patterns and impedance trends, the findings suggest significant calcification of the proximal coil relative to the distal coil.A defibrillation threshold test (dft) should be considered to ensure the system remains effective in a single coil configuration.The healthcare provider acknowledged and understood the recommendation.This device remains in service.This device was not returned for analysis.The product investigation determined that the "known inherent risk of device" investigation conclusion code was selected based on product record and reported observation review.Additional information was received that this crt-d was explanted and returned for analysis.Other than the surgical procedure, no additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN? CRT-D
Common Device Name
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key23359652
Report Number2124215-2025-75672
Device Sequence Number12979515
Product Code NIK
UDI-Device Identifier00802526534614
UDI-Public(01)00802526534614(17)190711
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
P010012
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/05/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date07/11/2019
Device Model NumberG150
Device Catalogue NumberG150
Device Lot Number487338
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/22/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/22/2025
Supplement Date Received by Manufacturer12/31/2025
Initial Report FDA Received Date10/22/2025
Supplement Report FDA Received Date01/05/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/10/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age71 YR
Patient SexFemale
-
-